Engdahl E, et al. Serological response against HHV-6A is associated with increased risk for multiple sclerosis. Abstract 222. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
ADORE: Samenwerken om kanker en hersenziekten beter te bestrijden
okt 2022 | Dementie, Immuuntherapie